PLYMOUTH MEETING, Pennsylvania (WPVI) -- The FDA has given the green light to a company in Plymouth Meeting, Pennsylvania to begin testing its vaccine for COVID-19.
Inovio Pharmaceuticals calls its new vaccine INO-4800.
The vaccine is based on the DNA of the coronavirus but does not use the actual virus.
Forty adult volunteers will get two doses of the vaccine a month apart, with the first results by early summer.
Testing will be done at the University of Pennsylvania and in Kansas City.
- Commissioner Outlaw speaks after Philadelphia Controller report
- Gov. Wolf outlines 2021 agenda following COVID-19 pandemic
WATCH VIDEOS
Welcome,
Your Account
Log Out
